Top

Published in:

01-01-2020 | Benign Prostatic Hypertrophy | Original Article

Monopolar enucleation versus transurethral resection of the prostate for small- and medium-sized (< 80 cc) benign prostate hyperplasia: a prospective analysis

Authors: Dmitry Enikeev, Leonid Rapoport, Magomed Gazimiev, Sergey Allenov, Jasur Inoyatov, Mark Taratkin, Ekaterina Laukhtina, John M. Sung, Zhamshid Okhunov, Petr Glybochko

Published in: World Journal of Urology | Issue 1/2020

Abstract

Aim

To assess efficacy and safety of monopolar enucleation of the prostate (MEP) and to compare it with the current treatment standard for medium-sized prostates, < 80 cc, transurethral resection of the prostate (TURP).

Methods

A prospective analysis patients undergoing a surgical procedure for their diagnosis of BPH (benign prostatic hyperplasia) (IPSS > 20, Q_max < 10; prostate volume < 80 cc) was performed. IPSS, Q_max were assessed preoperatively, at 6 and 12 months postoperatively. The complications were classified according to the modified Clavien–Dindo grading system.

Results

A total of 134 patients were included in the study: 70 underwent MEP and 64 - TURP for BPH (mean prostate volumes were comparable with p = 0.163). The mean surgery time was 44 min in the TURP group and 48.2 min in the MEP group, (p = 0.026). Catheterization time for MEP was 1.7 and 3.2 days for TURP (p < 0.001). Hospital stay for MEP was 3.2 days vs. 4.8 days for TURP (p < 0.001). Both techniques shown comparable efficiency in benign prostatic obstruction relief with IPSS drop in MEP from 23.1 to 5.9 and in TURP group from 22.8 to 7.3, whereas Q_max increased from 8.2 to 20.5 after MEP and from 8.3 and 19.9 after TURP. Urinary incontinence rate after catheter removal in TURP group was 9.0% and 7.8% in MEP group, at 1 year follow-up, it was 1.4% and 3.1% in MEP and TURP, respectively (p = 0.466).

Conclusions

Our experience demonstrated that MEP is an effective and safe BPH treatment option combining the efficacy of endoscopic enucleation techniques and accessibility of conventional TURP.

Oelke M, Bachmann A, Descazeaud A, Emberton M, Gravas S, Michel MC, N’Dow J, Nordling J, de la Rosette JJ, European Association of U (2013) EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction. Eur Urol 64(1):118–140. https://doi.org/10.1016/j.eururo.2013.03.004 CrossRefPubMed

Peyronnet B, Pradere B, Brichart N, Bodin T, Bertrand P, Members of French Group of GreenLight U, Bruyere F (2014) Complications associated with photoselective vaporization of the prostate: categorization by a panel of green light users according to Clavien score and report of a single-center experience. Urology 84(3):657–664. https://doi.org/10.1016/j.urology.2014.05.028 CrossRef

Mamoulakis C, de la Rosette JJ (2015) Bipolar transurethral resection of the prostate: darwinian evolution of an instrumental technique. Urology 85(5):1143–1150. https://doi.org/10.1016/j.urology.2015.01.003 CrossRefPubMed

Gravas S, Bach T, Bachmann A, Drake M, Gacci M, Gratzke C (2016) Management of non-neurogenic male lower urinary tract symptoms (LUTS), incl. Eur Assoc Urol, Benign Prostatic Obstruction (BPO) EAU Guidelines on

Li S, Zeng XT, Ruan XL, Weng H, Liu TZ, Wang X, Zhang C, Meng Z, Wang XH (2014) Holmium laser enucleation versus transurethral resection in patients with benign prostate hyperplasia: an updated systematic review with meta-analysis and trial sequential analysis. PLoS One 9(7):e101615. https://doi.org/10.1371/journal.pone.0101615 CrossRefPubMedPubMedCentral

Hiraoka Y, Lin T, Tsuboi N, Nakagami Y (1986) Transurethral enucleation of benign prostatic hyperplasia. Nihon Ika Daigaku Zasshi 53(2):212–215CrossRef

Herrmann TR (2016) Enucleation is enucleation is enucleation is enucleation. World J Urol 34(10):1353–1355. https://doi.org/10.1007/s00345-016-1922-3 CrossRefPubMed

Cornu JN, Ahyai S, Bachmann A, de la Rosette J, Gilling P, Gratzke C, McVary K, Novara G, Woo H, Madersbacher S (2015) A systematic review and meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic obstruction: an update. Eur Urol 67(6):1066–1096. https://doi.org/10.1016/j.eururo.2014.06.017 CrossRefPubMed

Mamoulakis C, de la Rosette J (2015) Bipolar transurethral resection of the prostate: darwinian evolution of an instrumental technique. Urology 85(5):1143–1150. https://doi.org/10.1016/j.urology.2015.01.003 CrossRefPubMed

10.

Rassweiler J, Teber D, Kuntz R, Hofmann R (2006) Complications of transurethral resection of the prostate (TURP)–incidence, management, and prevention. Eur Urol 50(5):969–979. https://doi.org/10.1016/j.eururo.2005.12.042 CrossRefPubMed

11.

Hiraoka Y, Akimoto M (1989) Transurethral enucleation of benign prostatic hyperplasia. J Urol 142(5):1247–1250CrossRef

12.

Hiraoka Y (2017) Transurethral endoscopic enucleation of the prostate (EEP). World J Urol 35(10):1629–1630. https://doi.org/10.1007/s00345-017-2019-3 CrossRefPubMed

13.

Glybochko PV, Alyaev YG, Rapoport LM, Enikeev DV, Okhunov Z, Netsch C, Spivak LG, Taratkin MS (2018) Endoscopic enucleation of the prostate: a short term trend or a new treatment standard? Urologiia 2:130–133CrossRef

14.

Ahyai SA, Gilling P, Kaplan SA, Kuntz RM, Madersbacher S, Montorsi F, Speakman MJ, Stief CG (2010) Meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic enlargement. Eur Urol 58(3):384–397. https://doi.org/10.1016/j.eururo.2010.06.005 CrossRefPubMed

15.

Gilling PJ, Kennett K, Das AK, Thompson D, Fraundorfer MR (1998) Holmium laser enucleation of the prostate (HoLEP) combined with transurethral tissue morcellation: an update on the early clinical experience. J Endourol 12(5):457–459. https://doi.org/10.1089/end.1998.12.457 CrossRefPubMed

16.

Pansadoro V, Emiliozzi P, Del Vecchio G, Martini M, Scarpone P, Del Giudice F, Veneziano D, Brassetti A, Assenmacher C (2017) Monopolar transurethral enucleation of prostatic adenoma: preliminary report. Urology 102:252–257. https://doi.org/10.1016/j.urology.2016.12.024 CrossRefPubMed

17.

Ajib K, Zgheib J, Salibi N, Zanaty M, Mansour M, Alenizi A, El-Hakim A (2018) Monopolar transurethral enucleo-resection of the prostate versus holmium laser enucleation of the prostate: a canadian novel experience. J Endourol 32(6):509–515. https://doi.org/10.1089/end.2017.0853 CrossRefPubMed

18.

Enikeev DV, Glybochko PV, Okhunov Z, Alyaev YG, Rapoport LM, Tsarichenko D, Enikeev ME, Sorokin NI, Dymov AM, Taratkin MS (2018) Retrospective analysis of short-term outcomes after monopolar versus laser endoscopic enucleation of the prostate: a single center experience. J Endourol 32:417–423. https://doi.org/10.1089/end.2017.0898 CrossRefPubMed

19.

Geavlete B, Stanescu F, Iacoboaie C, Geavlete P (2013) Bipolar plasma enucleation of the prostate vs open prostatectomy in large benign prostatic hyperplasia cases—a medium term, prospective, randomized comparison. BJU Int 111(5):793–803. https://doi.org/10.1111/j.1464-410X.2012.11730.x CrossRefPubMed

20.

Enikeev D, Glybochko P, Rapoport L, Gahan J, Gazimiev M, Spivak L, Enikeev M, Taratkin M (2018) A randomized trial comparing the learning curve of 3 endoscopic enucleation techniques (HoLEP, ThuFLEP, and MEP) for BPH using mentoring approach-initial results. Urology 121:51–57. https://doi.org/10.1016/j.urology.2018.06.045 CrossRefPubMed

21.

Choo MS, Lee HE, Bae J, Cho SY, Oh SJ (2014) Transurethral surgical anatomy of the arterial bleeder in the enucleated capsular plane of enlarged prostates during holmium laser enucleation of the prostate. Int Neurourol J 18(3):138–144. https://doi.org/10.5213/inj.2014.18.3.138 CrossRefPubMedPubMedCentral

22.

Shimizu Y, Hiraoka Y, Iwamoto K, Takahashi H, Abe H (2005) Measurement of residual adenoma after transurethral resection of the prostate by transurethral enucleation technique. Urol Int 74(2):102–107. https://doi.org/10.1159/000083278 CrossRefPubMed

Title: Monopolar enucleation versus transurethral resection of the prostate for small- and medium-sized (< 80 cc) benign prostate hyperplasia: a prospective analysis
Authors: Dmitry Enikeev
Leonid Rapoport
Magomed Gazimiev
Sergey Allenov
Jasur Inoyatov
Mark Taratkin
Ekaterina Laukhtina
John M. Sung
Zhamshid Okhunov
Petr Glybochko
Publication date: 01-01-2020
Publisher: Springer Berlin Heidelberg
Keywords: Benign Prostatic Hypertrophy
Benign Prostatic Hypertrophy
Transurethral Prostate Resection
Laser
Published in: World Journal of Urology / Issue 1/2020
Print ISSN: 0724-4983
Electronic ISSN: 1433-8726
DOI: https://doi.org/10.1007/s00345-019-02757-z

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Monopolar enucleation versus transurethral resection of the prostate for small- and medium-sized (< 80 cc) benign prostate hyperplasia: a prospective analysis

Abstract

Aim

Methods

Results

Conclusions

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Aim

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2020

A systematic review of the clinical significance of nephrostomy urine cultures

Current status of urology surgical training in Europe: an ESRU–ESU–ESUT collaborative study

Diagnostic ureteroscopy prior to nephroureterectomy for urothelial carcinoma is associated with a high risk of bladder recurrence despite technical precautions to avoid tumor spillage

Condition-specific surveillance in health care-associated urinary tract infections as a strategy to improve empirical antibiotic treatment: an epidemiological modelling study

A phase 3, open-label, multicenter study of a 6-month pre-mixed depot formulation of leuprolide mesylate in advanced prostate cancer patients

Concomitant carcinoma in situ may not be a prognostic factor for patients with bladder cancer following radical cystectomy: a PRISMA-compliant systematic review and meta-analysis